Related Experiment Video
Updated: Aug 12, 2026

08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Predictive medicine by cytomics: potential and challenges
1Max-Planck-Institut für Biochemie, Martinsried, Germany. valet@biochem.mpg.de
Journal of Biological Regulators and Homeostatic Agents
|July 30, 2002
Summary
Predictive medicine uses cytomics to forecast individual disease progression based on molecular cell phenotypes. This approach enables personalized preventive therapies and aids in understanding complex disease mechanisms.
Area of Science:
- Biomedical Science
- Computational Biology
- Genomics
Background:
- Predictive medicine aims to forecast disease courses for individual patients.
- Molecular cell phenotypes, influenced by genotype and environmental factors, are key to disease prediction.
- Current predictive models require dynamic, therapy-dependent adjustments.
Purpose of the Study:
- To introduce cytomics as a novel concept for predictive medicine.
- To leverage molecular cell phenotypes for personalized disease course predictions.
- To explore the utility of predictive data patterns for hypothesis generation in complex diseases.
Main Methods:
- Utilizing multiparametric data from cytometry, clinical chemistry, and arrays.
- Employing an algorithmic data sieving procedure for parameter enrichment.
- Developing standardized data masks for predictive and diagnostic classification.
Main Results:
- Cytomics provides dynamic, therapy-dependent disease course predictions.
- Enriched discriminatory parameters facilitate individual patient classification.
- Identified data patterns can inform hypotheses on disease mechanisms.
Conclusions:
- Cytomics offers a powerful framework for predictive and diagnostic medicine.
- Personalized predictions can guide preventive strategies and mitigate tissue damage.
- This approach facilitates a bottom-up discovery of disease pathogenesis.
Related Concept Videos
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Flow Cytometry
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
In...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

